Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocation sections were updated to include North Carolina and Kerala as study sites, and the page revision was updated to v3.3.3. The previous placement of these locations was removed in the v3.3.2 update.SummaryDifference0.3%

- Check47 days agoChange DetectedThe page shows a new revision tag, v3.3.2, replacing v3.3.1. No study data or eligibility information is affected.SummaryDifference0.1%

- Check54 days agoChange DetectedPublications are now described as automatically filled from PubMed and possibly not related to the study, with the revision updated to v3.3.1. The deletion text was revised to reflect automatic PubMed sourcing and generation by the NCT number, with the revision noted as v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the funding-status banner that warned data may be out of date and pointed users to NIH/OPM status pages.SummaryDifference0.4%

- Check76 days agoChange DetectedThe updates show minor formatting and layout adjustments; core study information such as GA-GCB vs imiglucerase, eligibility criteria, and outcome measures appears unchanged.SummaryDifference0.3%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.